Corrigendum to “EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors” [Biomed. Pharmacother. 192 (2025), 118704]

Biomedicine & Pharmacotherapy 2026 Open access

Read full text
Authors: Bernhard Haller, G. Richter, Marco Wachtel, Lena Schuler, Carla Regina, Bernhard Willibald Renz, Marvin Jens, Ingrid Bechtold, Yekaterina Gadasheva, Ebrahem Hamed, Samanta Kisele, Mathilda Knoblauch
+11 more Maximilian R. Koch, Dmitry Lupar, Satoshi Nakano, Katharina Pardon, Paul J Pärschke, Claudia Winter, Ulf Toelch, Beat W. Schäfer, Ana Banito, Irene Teichert von Lüttichau, Simone Hettmer
DOI: 10.1016/j.biopha.2026.119120
Cited by: 0

Fields of Study & Subjects

Protein Degradation and Inhibitors Sarcoma Diagnosis and Treatment Chromatin Remodeling and Cancer

Publication details

Journal / source
Biomedicine & Pharmacotherapy
Volume
196
Pages
119120–119120
Publication date
13 February 2026
Language
EN